Literature DB >> 18832509

Dosing frequency and adherence to antipsychotic medications.

Paul N Pfeiffer1, Dara Ganoczy, Marcia Valenstein.   

Abstract

OBJECTIVES: This study investigated whether dosing frequency affects antipsychotic medication adherence among patients with schizophrenia.
METHODS: Databases from the Department of Veterans Affairs were used to assess adherence among patients with a diagnosis of schizophrenia. Adherence was measured by using antipsychotic medication possession ratios (MPRs). Adherence was compared among patients who experienced an increase or decrease in dosing frequency and among patients on stable regimens of once-daily or more than once-daily dosing.
RESULTS: Among patients with a dose increase (N=1,639), those with increases in dosing frequency (N=258) had a mean change in MPRs of -.105, compared with -.002 for those without a dosing frequency change (N=1,381) (p<.001). Patients with decreases in dosing frequency (N=1,370) had a small but significant increase in mean MPRs (MPR change=.045) when compared with 2,740 patients without a dosing frequency change (MPR change=-.018) (p<.001). Among patients on stable regimens (N=32,612), there were no significant differences in MPRs between those receiving once-daily dosing (MPR=.80) and those receiving more than once-daily dosing (MPR=.80).
CONCLUSIONS: Among patients on less stable dosing regimens, increases in dosing frequency may result in modest decreases in adherence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832509     DOI: 10.1176/ps.2008.59.10.1207

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  13 in total

Review 1.  Evaluation of the clinical efficacy of asenapine in schizophrenia.

Authors:  Arpi Minassian; Jared W Young
Journal:  Expert Opin Pharmacother       Date:  2010-08       Impact factor: 3.889

2.  Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies.

Authors:  John M Kane; Taishiro Kishimoto; Christoph U Correll
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

Review 3.  Blonanserin: a review of its use in the management of schizophrenia.

Authors:  Emma D Deeks; Gillian M Keating
Journal:  CNS Drugs       Date:  2010-01       Impact factor: 5.749

4.  [Risk factors for treatment adherence in patients with schizophrenia: case-control study].

Authors:  Chadya Aarab; Fatima Elghazouani; Rachid Aalouane; Ismail Rammouz
Journal:  Pan Afr Med J       Date:  2015-03-20

Review 5.  Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies.

Authors:  Peter M Haddad; Cecilia Brain; Jan Scott
Journal:  Patient Relat Outcome Meas       Date:  2014-06-23

6.  Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis.

Authors:  Goran Medic; Kyoko Higashi; Kavi J Littlewood; Teresa Diez; Ola Granström; René S Kahn
Journal:  Neuropsychiatr Dis Treat       Date:  2013-01-16       Impact factor: 2.570

7.  Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis.

Authors:  Kunal Srivastava; Anamika Arora; Aditi Kataria; Joseph C Cappelleri; Alesia Sadosky; Andrew M Peterson
Journal:  Patient Prefer Adherence       Date:  2013-05-20       Impact factor: 2.711

Review 8.  Tackling nonadherence in psychiatric disorders: current opinion.

Authors:  Saeed Farooq; Farooq Naeem
Journal:  Neuropsychiatr Dis Treat       Date:  2014-06-12       Impact factor: 2.570

9.  Assessment of Real-Life Outcomes in Schizophrenia Patients according to Compliance.

Authors:  Zaina P Qureshi; Rezaul Khandker; Jason Shepherd; Salome Samant; Farid Chekani; Hollie M L Bailey
Journal:  Psychiatry J       Date:  2020-08-31

10.  Mental Health Nurses' Tacit Knowledge of Strategies for Improving Medication Adherence for Schizophrenia: A Qualitative Study.

Authors:  Yao-Yu Lin; Wen-Jiuan Yen; Wen-Li Hou; Wei-Chou Liao; Mei-Ling Lin
Journal:  Healthcare (Basel)       Date:  2022-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.